后程加速超分割三维适形放疗同步化疗治疗食管癌的疗效分析

邵海君; 洪伟丰; 应军盛; 何伟岳; 陆启轮

doi:10.3969/j.issn.1671-038X.2016.02.06

后程加速超分割三维适形放疗同步化疗治疗食管癌的疗效分析

- 舟山医院放疗科, 浙江舟山 316004

详细信息

作者简介:
邵海君,本科,主要从事肿瘤放射治疗工作

通讯作者: 邵海君,E-mail:shaohj2000@126.com

中图分类号: R735.1

收稿日期: 2015-08-03

Efficacy of three dimensional conformal late course accelerated hyperfraction radiotherapy and concurrent chemotherapy on esophageal carcinoma

- Department of Radiotherapy, Zhoushan Hospital, Zhoushan 316004, China

More Information

Corresponding author: SHAO Hai-jun, E-mail: shaohj2000@126.com

Received Date: 03 August 2015

摘要

摘要: [目的]观察后程加速超分割三维适形放疗联合同步化疗治疗中晚期食管癌的临床疗效。[方法]104例中晚期食管癌患者随机分为2组，观察组（51例）采取后程加速超分割三维适形放疗联合紫杉醇、奈达铂化疗治疗；对照组（53例）仅行后程加速超分割三维适形放疗。观察指标为治疗后3个月疗效、1年生存率及不良反应发生率，并采用EORTC癌症患者生命质量测定量表QLQ-C30（V3.0）中文版评价治疗前后生命质量。[结果]治疗后3个月，观察组有效率显著高于对照组（P<0.05）。1年生存率比较，观察组高于对照组，但差异无统计学意义。治疗前2组QLQ-C30量表指标比较差异无统计学意义，治疗结束时观察组躯体功能、角色功能、情绪功能、社会功能评分显著低于对照组，而总体症状明显高于对照组（P<0.05）。治疗后3个月，观察组躯体功能、情绪功能、社会功能评分高于对照组，而总体症状评分低于对照组，差异有统计学意义（P<0.05）。观察组不良反应发生率高于对照组（P<0.05）。[结论]后程加速超分割三维适形放疗联合同步化疗治疗食管癌能提高近期疗效，虽不良反应增多，影响治疗期间生命质量评分，但均可耐受，短期内即可恢复且有提高。
- 食管肿瘤 /
- 放射疗法,适形 /
- 化学疗法
Abstract: [Objective] To evaluate the efficacy of three dimensional conformal late course accelerated hyperfraction radiotherapy(LCAFR-3 DCRT) and concurrent chemotherapy for middle-advanced esophageal carcinoma.[Methods] One hundred and four cases of middle-advanced esophageal cancer were divided into two groups.The observation group was treated with LCAFR-3 DCRT plus 2 cycles of concurrent chemotherapy(Paclitaxel+Nedaplatin), and the control group was treated with LCAFR-3 DCRT only.Clinical efficacy after 3 months, 1-year survival rates and adverse reaction were observed, and EORTC QLQ-C30 was used to evaluate the life quality before and after treatment.[Results] The clinical efficacy in the observation group after 3 months of treatment was higher than the control group(82.4% vs 64.2%, χ²=4.377, P<0.05).There was no significant difference of 1-year survival rates between the two groups.At the endpoint, the scores of somatic function, role function, emotional function and social function in the observation group were significantly lower than those in the control group, and the score of general symptoms was higher.But 3 months later, the scores of somatic function, emotional function and social function in the observation group were significantly higher than those in the control group, and the score of general symptoms was lower.The adverse reaction was severer in the observation group than in the control group, [Conclusion] LCAFR-3 DCRT combined with concurrent chemotherapy for esophageal carcinoma can improve the short-term clinical efficacy.Although this treatment has more adverse reactions and affects the life quality of patients during the treatment, they can be tolerated and will recover and improve in a short term.
- esophageal neoplasms /
- radiotherapy,conformal /
- chemotherapy

HTML全文

参考文献(14)

[1]	RICE T W.Esophageal Cancer Staging[J].Korean J Thorac Cardiovasc Surg, 2015, 48:157-163.
[2]	唐安球.食管癌治疗现状及进展[J].医学综述, 2014, 20(1):39-41.
[3]	蔡群榕.3D-CRT联合化疗与单纯放疗治疗食管癌老年患者的疗效及安全性对比[J].中国老年学杂志, 2013, 33(21):5461-5462.
[4]	DAI T, SHAH M A.Chemoradiation in oesophageal cancer[J].Best Pract Res Clin Gastroenterol, 2015, 29:193-209.
[5]	KUBOTA K, KURODA J, YOSHIDA M, et al.Surgical therapy and chemoradiotherapy for postoperative recurrent esophageal chemoradiotherapy cancer[J].Hepato Gastroenterology, 2012, 60:1961-1965.
[6]	周明镇, 郭竑, 翟田田, 等.单纯放疗与同期放化疗治疗食管癌的效果比较[J].广东医学, 2015, 36(1):110-113.
[7]	SHRIDHAR R, ALMHANNA K, MEREDITH K L, et al.Radiation therapy and esophageal cancer[J].Cancer Control, 2013, 20:97-110.
[8]	SONG Y P, MA J B, HU L K, et al.Phase I/II study of hypofractioned radiation with three-dimensional conformal radiotherapy for clinical T3-4N0-1M0stage esophageal carcinoma[J].Technol Cancer Res Treat, 2011, 10:25-30.
[9]	WANG J H, LU X J, ZHOU J, et al.A randomized controlled trial of conventional fraction and late course accelerated hyperfraction three-dimensional conformal radiotherapy for esophageal cancer[J].Cell Biochem Biophys, 2012, 62:107-112.
[10]	JEMAL A, BRAY F, CENTER M M, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61:69-69.
[11]	朱琪伟, 黄灿红, 万志龙, 等.奈达铂同步放化疗治疗老年食管癌的疗效观察[J].中国医药, 2013, 8(5):643-645.
[12]	辜树勇, 林少波, 傅俊惠, 等.紫杉醇脂质体联合奈达铂行食管癌新辅助化学治疗的近期疗效观察[J].新医学, 2013, 44(5):323-325.
[13]	张慧荣, 姜宏宁, 杨波, 等.音乐疗法对老年恶性肿瘤患者临终期生命质量的影响[J].中华老年多器官疾病杂志, 2015, 14(6):458-462.
[14]	van der KLOOT W A, KOBAYASHI K, YAMAOKA K, et al.Summarizing the fifteen scales of the EORTC QLQ-C30questionnaire by five aggregate scales with two underlying dimensions:a literature review and an empirical study[J].J Psychosoc Oncol, 2014, 32:413-430.